Cargando…
Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use
BACKGROUND: Some people who suffer an upper gastrointestinal bleed or perforation die. The mortality rate was estimated at 12% in studies published before 1997, but a systematic survey of more recent data is needed. Better treatment is likely to have reduced mortality. An estimate of mortality is he...
Autores principales: | Straube, Sebastian, Tramèr, Martin R, Moore, R Andrew, Derry, Sheena, McQuay, Henry J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2698873/ https://www.ncbi.nlm.nih.gov/pubmed/19500343 http://dx.doi.org/10.1186/1471-230X-9-41 |
Ejemplares similares
-
Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice
por: Moore, R Andrew, et al.
Publicado: (2006) -
Topical NSAIDs for acute pain: a meta-analysis
por: Mason, Lorna, et al.
Publicado: (2004) -
Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis
por: Mason, Lorna, et al.
Publicado: (2004) -
What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs
por: Moore, R Andrew, et al.
Publicado: (2008) -
Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk
por: Moore, R Andrew, et al.
Publicado: (2007)